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Abstract: Background: Several reports have documented the influence of ABO blood group on plasma von Willebrand 
Factor Antigen (vWF:Ag) levels. However, a thorough search through the literature has not revealed any study on the 
relationship between Rh blood group and plasma von Willebrand Factor antigen levels. 
Objective: The aim of this study was to determine the relationship between plasma vWF:Ag levels and Rh(D) blood 
group among apparently healthy Nigerian subjects. 
Methods: This was a cohort study of 100 Blood Donors attending the Blood Bank Unit at University of Uyo Teaching 
Hospital, Uyo, Nigeria. Plasma vWF:Ag levels were determined by ELISA method while the ABO and Rh(D) blood group 
phenotypes were determined using the standard tube method. The data were analyzed with SPSS version 16.0. Chi 
square was used for test of significance. 
Results: The study population consisted of 63 (63%) males and 37 (37%) females with a mean age of 31.7 ± 6.39 years. 
The frequency of Rh(D) positive and Rh(D) negative blood groups were 95% and 5%, respectively. The mean plasma 
vWF:Ag concentration of the subjects was 1.38 ± 1.02 IU/ml. Group B Rh(D) positive subjects had the highest mean 
vWF:Ag level (2.27 ± 1.57 IU/ml), followed by group O Rh (D) negative (2.00 ± 1.04 IU/ml), group AB Rh(D) positive 
(1.69 ± 1.06 IU/ml), group B Rh(D) negative (1.53 ± 0.57 IU/ml), group O Rh(D) positive (1.24 ± 1.00 IU/ml) and group A 
Rh(D) positive (1.08 ± 0.40 IU/ml) having the lowest level. 
Conclusion: There was no statistically significant association between the plasma vWF:Ag levels and Rh(D) blood 
groups of study subjects (P = 0.1546). However, further research with larger sample size is required to determine the 
relationship between plasma vWF:Ag levels and Rh blood group in general before reaching definite conclusion about the 
lack of influence of Rh blood group on the plasma level of vWF:Ag 
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INTRODUCTION 
The Rh blood group system, formerly referred to as 
Rhesus blood group system, was discovered in 1940 
by Karl Landsteiner and A. S. Wiener [1]. It is 
unarguably the most polymorphic protein-based blood 
group system. With more than 60 antigens so far 
described, it is the largest blood group known in 
humans. The usually large number of Rh antigens is 
attributable to its intricate genetic basis [2]. These 
antigens (Rh D and Rh CE determinants) consist of 
complex protein molecules expressed in the membrane 
of red blood cells and their immediate precursors [3]. 
Thus, Rh matching is crucial in blood transfusion and 
stem cell transplantation [4]. 
The Rh blood group is second in its clinical 
importance only to the ABO blood group in the field of 
transfusion medicine [5]. It is of utmost relevance in 
Obstetrics, being the major cause of haemolytic 
disease of the newborn (HDN) [6]. Its significance is 
related to the fact that the Rh antigens, particularly the  
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D antigen, are highly immunogenic. In the case of the 
D antigen, individuals who do not express D antigen on 
their red cells will produce anti-D antibodies if they 
encounter the D antigen on transfused RBCs (causing 
a haemolytic transfusion reaction, HTR) or on fetal 
RBCs (causing haemolytic disease of the newborn, 
HDN) [6, 7]. Aside from its importance in blood 
transfusion practice, the Rh blood group is useful in 
population genetic studies, researching population 
migration patterns as well as resolving certain medico-
legal issues, especially of disputed paternity cases [8, 
9]. Also, its relation to myeloid diseases such as acute 
or chronic myeloid leukaemia, myeloid metaplasia, 
polycythaemia vera and myelofibrosis has been 
reported [10]. However, studies on the role of Rh blood 
group in haemostasis are few and far between. 
Furthermore, there are no published reports on the 
relationship between Rh blood group and von 
Willebrand Factor Antigen. 
Von Willebrand Factor is named after Dr. Erik von 
willebrand, a Finnish Paediatrician who first described it 
in 1926. It is a large multimeric protein produced in the 
endothelial cells and megakaryocytes. It mediates 
adhesion and aggregation of platelets in blood vessels 
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and also serves as a carrier molecule for Factor VIII 
(FVIII) protein in plasma [11]. Deficiency of vWF:Ag 
results in von Willebrand Disease, the most common 
inherited bleeding disorder in humans [12]. 
Several factors are known to affect the plasma 
concentration of vWF:Ag. About 60% of the variations 
are caused by genetic factors, with ABO blood group 
accounting for about 30% while 20% of the variability 
can be traced to the vWF gene [13, 14]. Environmental 
Factors such as age, stress, exercise, pregnancy and 
drugs account for the remainder [15]. 
Multiple studies have consistently reported that 
ABO blood group has a profound effect on the plasma 
levels of vWF:Ag [13,14,16,17]. However, as earlier 
highlighted, there is no study addressing the effect of 
Rh blood group on vWF:Ag in the literature. Thus, this 
study seeks to examine the relationship between Rh 
blood group and plasma vWF:Ag level. It is envisaged 
that information from this work would add to existing 
body of knowledge as well as serve as a template for 
further research  
MATERIALS AND METHODS 
Study Site/Design 
This was a cross-sectional descriptive study of 100 
blood donors who attended the blood bank unit of the 
University of Uyo Teaching Hospital (UUTH), a tertiary 
referral hospital in Uyo, Akwa Ibom State, South-south 
Nigeria. The hospital provides specialized healthcare 
services to the indigenes of Uyo and its environs with a 
population of 4 million people [18]. 
Inclusion and Exclusion Criteria 
Apparently healthy, consenting subjects, between 
the ages of 18 and 65 years were included in the study. 
Non consenting subjects and those on medications 
such as anticoagulants, contraceptives, anti-platelet 
drugs and herbal concoctions were excluded. 
Procedure 
10ml of free-flowing venous blood was obtained 
from each subject under aseptic condition. Half (5ml) of 
this was dispensed into ethylene-diamine – tetracetate 
(EDTA) bottles for full blood count (FBC), ABO and 
RhD blood grouping. The second aliquot of 5ml of 
blood was dispensed into a trisodium citrate specimen 
bottle, and centrifuged at 3000g for 10minutes at 40C 
within 30 minutes of collection and stored in aliquots at 
– 800C for use in the determination of baseline 
prothrombin time (PT), activated partial thromboplastin 
time (APTT) and vWF:Ag within a week. All samples 
collected were labeled with a serial number allotted to 
each subject. 
The full blood count (FBC) was carried out using the 
Sysmex Haematology Analyzer. Standard tube method 
as described by Dacie and Lewis [19] was used for the 
determination of ABO blood group using antisera 
obtained from Biotec Laboratory, United Kingdom. 
Plasma concentration of vWF:Ag was estimated using 
a commercial assay kit – Assay max human von 
Willebrand Factor (vWF) ELISA kit manufactured by 
Assay pro, St. Charles, MO, USA. The PT/APTT time 
were determined using standard commercial PT/APTT 
reagents manufactured by Diagnostic Reagent Ltd, 
Thames, Oxon, United Kingdom. Adequate controls 
were included in all tests carried out. 
Data Analysis 
The data were collated, analyzed using statistical 
package for social sciences (SPSS) windows version 
16.0 and presented in simple frequency tables. The 
comparisons were carried out with chi-square test as 
appropriate and the p-value of less than 0.05 was used 
to determine the level of statistical significance. 
Ethical Consideration 
This study was conducted after receiving 
appropriate approval from Ethics and Research 
committee of our hospital. Informed consent was 
obtained in writing from all subjects. 
RESULTS 
A total of 100 blood donors, aged 21 – 53years 
(mean age 31.7 + 6.39years; 63 males, 37 females) 
were included in the study. Age and sex distribution of 
the donors are summarized in Table 1. 
Donors with blood group O+ were the majority with a 
total of 47 subjects (47%) and mean vWF:Ag level of 
1.24 ± 1.00 IU/ml while group B- had the least with 2 
subjects (2%) with mean vWF:Ag level of 1.53 ± 0.57 
IU/ml. Subjects with blood group A+ were a total of 31 
(31%) and had a vWF:Ag level of 1.08 ± 0.40 IU/ml, 
while subjects with B+ accounted for 14 (14%) with 
mean vWF:Ag level of 2.27 ± 1.57 IU/ml. Blood groups 
O- and AB+ accounted for 3 (3%) each and had mean 
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vWF:Ag levels of 2.00 ± 1.04 IU/ml and 1.67 ± 1.06 
IU/ml, respectively. Table 2a shows the distribution of 
vWF:Ag levels among the various ABO and Rh(D) 
blood groups. 
Results showed that subjects with non-O blood 
group had a plasma vWF:Ag level significantly higher 
than those of group O (Table 2b) 
Table 2: Distribution of von-Willebrand Factor Antigen 
Concentration (vWF:Ag, lU/ml) among the ABO 
and Rh(D) Blood Groups of Blood Donors in 
UUTH, Uyo 
(a) Blood Group Mean Standard Deviation 
 A+ 1.08 0.402 
 AB+ 1.686 1.0608 
 B+ 2.27 1.57 
 B- 1.53 0.57 
 O+ 1.24 1.00 
 O- 2.00 1.04 
  1.38 1.02 
 
(b) Non – O 1.468 1.0406 
 O 1.289 1.005 
  1.38 1.02 
 
A comparison of the mean vWF:Ag levels of the 
various ABO blood groups using kruskal Wallis rank 
test showed that the differences between their means 
were statistically significant (P < 0.05). Table 3 shows 
the relationship between mean plasma vWF:Ag 
concentrations and ABO blood groups of the donors 
while Table 4 shows the relationship between mean 
plasma vWF:Ag concentrations and ABO and Rh blood 
groups (P < 0.05). However, there was no statistically 
significant difference between the plasma vWF:Ag 
concentration and the Rh (D) blood group (Table 5). 
Table 3: Relationship between Mean Plasma vWF:Ag 
Concentration (lU/ml) and ABO Blood Groups 
of 100 Donors of UUTH, Uyo 
ABO Blood Group Frequency (n) Kruskal Wallis 
A 31 1394.00 
AB 3 184.00 
B 16 1161.50 
O 50 2310.50 
Chi-square = 11,918 with 3df, P = 0.0077 
 
Table 4: Relationship between Plasma vWF:Ag 
Concentration lU/ml and ABO and Rh (D) Blood 
Groups of Donors at UUTH, Uyo 
ABO Blood Group Frequency (n) Kruskal Wallis Rank Sum 
O+ 47 2102.00 
A+ 31 1394.00 
B+ 14 1027.50 
AB+ 3 184.00 
O- 3 208.50 
B- 2 134.00 
Chi-square = 14,060 with 5df, P = 0.0152 
 
Table 5: Relationship between Plasma vWF:Ag 
Concentration lU/ml and Rh(D) Blood Groups 
of the Blood Donors 
Blood Group Observation (n) Rank Sum Z- Value p 
RhD+ 95 4707.5 1.44 0.1546 
RhD- 5 342.5   
n = no of observations  
DISCUSSION 
The main objective of this study was to investigate 
whether there is any relationship between Rh(D) blood 
group and plasma von Willebrand Factor Antigen level 
using a cohort of 100 blood donors in a Southern 
Nigerian population. The literature is replete with 
publications of an association of plasma von Willebrand 
Factor Antigen level with many biologic factors. Von 
Table 1: Age and Sex Distribution of 100 Blood Donors 
in UUTH, Uyo 
Age group (years) Frequency (n) Percentage (%) 
20-29 25 25 
30-39 60 60 
40-59 10 10 
50-59 5 5 
60-69 - - 
70+ - - 
Total 100 100 
 
Sex   
Male 63 63 
Female 37 37 
Total 100 100 
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Willebrand Factor antigen has been known to vary 
widely in healthy individuals [16, 17, 20]. Both 
environmental and genetic factors contribute to this 
variation. Increased levels of vWF:Ag are associated 
with stress, exercise, advancing age, pregnancy and 
when oestrogen levels are raised [15]. The 
environmental factors are known to stimulate the 
endothelial cells to secrete vWF, whereas the genetic 
factors play a dominant role in determining the baseline 
level of vWF. Genetic factors are thought to account for 
70% of the variability, of which approximately 30% is 
due to the effect of ABO blood group [16]. Several 
studies have documented the influence of ABO blood 
group on plasma vWF levels [13, 14, 16, 17]. Despite 
the prodigious body of evidence which affirms the 
effect of ABO blood group on plasma levels of vWF:Ag, 
the role of Rhblood group has remained elusive, as 
previous studies have primarily focused on the former 
blood group. It is in the context of the foregoing that we 
considered it imperative to undertake this study. 
In the present study, the influence of ABO blood 
group on plasma von Willebrand Factor antigen level 
was also evident. We observed a statistically significant 
association between ABO blood group and plasma 
vWF:Ag levels (Tables 3 and 4). Also, vWF:Ag levels 
were found to be lower in blood group O subjects 
compared to non-O subjects (Table 2b). This is 
consistent with earlier reports [14, 16, 17]. The 
plausible explanation for this observation involves the 
effect of the ABO locus and altered susceptibility of the 
different ABH determinants to cleavage by ADAMTS13 
(a disintegrin and metalloproteinase with thrombos- 
pondin type – 1 repeats – 13) metalloprotease. vWF is 
one of the few non- erythrocyte proteins that expresses 
ABH antigens and ABH oligosaccharide structures 
have been identified on the N-linked oligosaacharide 
chains of vWF. These side chains contain A and B 
blood group antigens which are encoded by the ABO 
blood group gene, located on the long arm of 
chromosome 9. The presence of A and B antigens 
leads to decreased susceptibility of vWF to cleavage by 
ADAMTS13. Thus, individuals with blood groups A, B 
and AB (non – O blood groups have approximately 
25% higher vWF:Ag levels than individuals with blood 
group O [21]. A similar finding has been reported in a 
study done by kumara and associates [22]. 
Furthermore, Bowen et al. [23] reported that 
increased vWF clearance is significantly faster for 
group O compared to non-group O vWF persons in the 
following order: O ≥ B > A≥ AB. The mechanism by 
which ABO blood group influences the catabolism of 
vWF is not understood fully, but two N-linked potential 
glycosylation sites (asparagines 1515 and 1574) are 
located in close proximity to the ADAMTS13 cleavage 
site (Tyr 1605 – met 1606 bond within the A2 domain of 
vWF). Therefore, the oligosaccharide chain composi- 
tion may be responsible for stabilizing the conformation 
of this vWF region, such that the removal of terminal 
sugar permits the A2 domain to adopt a configuration 
more permissive for ADAMTS13 proteolysis [24]. 
In relation to Rh status, the result of this study did 
not show any statistically significant association 
between the Rh(D) blood group and the plasma 
vWF:Ag concentration. Interestingly though, this study 
has established for the first time that Rh(D) phenotype 
is not a modulator of plasma vWF:Ag level. However, 
further studies with larger sample size are needed to 
examine the effects, if any, of the other Rh phenotypes 
or genotypes. 
CONCLUSION 
This study has shown that plasma vWF:Ag levels in 
healthy Nigerian subjects vary widely. It is also evident 
from this work that ABO blood group but not Rh(D) 
blood group has a significant influence on plasma 
vWF:Ag levels and needs to be taken into cognizance 
when establishing reference range for vWF:Ag. 
However, we recommend that further studies including 
community – based survey with larger sample size 
should be conducted in other parts of the world to 
determine the relationship between the Rh blood group 
in general and plasma vWF:Ag concentration for the 
purpose of validating the present observation. It is 
hoped that this work will form the basis for a more 
extensive prospective study in the nearest future. 
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